Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 523144 | NSE Symbol : MEDICAPS | ISIN : INE442D01010 | Industry : Construction |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
03-Feb-2025	12-Feb-2025	Quarterly Results	MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve 1.To consider and approve the Standalone as well as Consolidated Un-Audited Financial Results of the Company for the quarter as well as nine months ended on 31st December 2024 along with the Limited Review Report thereon. 2.Other routine matters with the permission of chair. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that, Board of Directors at their meeting held on today i.e. Wednesday 12th February, 2025 has inter alia considered and approved the following businesses: (1) Un-audited Standalone and Consolidated Financial Results of the Company for the quarter as well as nine months ended on 31st December, 2024 along with the Limited Review Report thereon. (2) Review and approve policy on Related Party Transactions w.e.f. 12th February, 2025. (3) Other routine businesses with the permission of chair. Integrated Filing (Financial) for the quarter 31.12.2024 (As Per BSE Announcement Dated on 12/02/2025)
06-Nov-2024	12-Nov-2024	Quarterly Results	MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve 1.To consider and approve the Standalone as well as Consolidated Un-Audited Financial Results of the Company for the quarter as well as half year ended on 30th September 2024 along with the Limited Review Report thereon. 2.Other routine matters with the permission of chair. Un-audited standalone and consolidated financial results for the quarter and half year ended 30.09.2024. (As per BSE Announcement dated on 12/11/2024)
01-Aug-2024	07-Aug-2024	Quarterly Results	MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve 1.To consider and approve the Standalone as well as Consolidated Un-Audited Financial Results of the Company for the quarter ended on 30th June 2024 along with the Limited Review Report thereon. 2.Other routine matters with the permission of chair. The Board of Directors at their meeting held on Wednesday i.e. 07th August, 2024 has inter alia considered and approved the following businesses: (1) Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended on 30th June, 2024 along with Limited Review Report thereon. (2) Board's Report on the operations of the Company along with required annexure and Corporate Governance Report and Management Discussion and Analysis Report for the year ended 31st March, 2024. (3) Continuation of directorship of Mrs. Kusum Mittal (DIN: 00035356), on attaining the age of 75 (seventy-five) years. (4) Convening of 41st Annual General Meeting (AGM) (5) Change of Registered Office outside the local limits of city, town or village, w.e.f. 01st October, 2024 subject to approval of members in ensuing 41st Annual General Meeting. (6) Other routine businesses with the permission of chair. (As Per BSE Announcement dated on 07.08.2024)
15-May-2024	23-May-2024	Quarterly Results	MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 inter alia to consider and approve 1. The Standalone as well as Consolidated Audited Financial Results of the Company for the fourth quarter as well as financial year ended on 31st March 2024 along with auditors report thereon. 2. Other routine matters with the permission of chair. The Board of Directors of the company in their meeting held on 23rd May, 2024 has inter alia considered and approved the following businesses: 1. Audited standalone and consolidated financial results for the fourth quarter as well as year ended 31.03.2024 along with the auditor report, statement of assets and liabilities, cash flow statement. 2. Declaration regarding unmodified opinion of the auditors on annual audited audited financial results. 3. Re- Appointment of Internal Auditor. 4. Re-Appointment of Secretarial Auditor. 5. Other routine business with the permission of the chair. The Board of directors of the company at its meeting held on 23.05.2024 inter alia considered and approved the matter as mentioned in the letter. Re-appointment of Secretarial auditor for the financial year 2024-25 (As per BSE Announcement Dated on 23/05/2024)
31-Jan-2024	08-Feb-2024	Quarterly Results	MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve the standalone and consolidated un-audited financial results of the Company for the quarter/nine month ended 31.12.2023 and to consider other routine matters with the permission of the chair. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that, Board of Directors at their meeting held on today i.e. 08th February, 2024 has inter alia considered and approved the following businesses: (1) Approval of the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter as well as nine months ended on 31st December, 2023 along with Limited Review Report thereon. (2) Reconstitution of Audit Committee, Nomination and Remuneration Committee and Stakeholder Relationship Committee w.e.f. 01st April, 2024. (3) Other routine businesses with the permission of chair. (As per BSE Announcement Dated on 08/02/2024)
01-Nov-2023	08-Nov-2023	Quarterly Results	MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve With reference to the subject captioned above and in terms of Regulation 29 of SEBI (Listing obligation and disclosure Requirement) 2015 we are pleased to inform that 03/2023-24 meeting of board of directors of the company to be held on Wednesday 08th November 2023 at corporate office of the Company to transact the following business: 1. To consider and approve standalone as well as consolidated un-audited financial result of the company for the quarter/half year ended 30th September 2023. 2. To Consider any other matter with the permission of the Chair. Outcome of 03/2023-24 board meeting held on 08.11.2023 Financial Result for the quarter/half year ended 30.09.2023 Company has appointed Mr. Akshit Garg as General Manager and Mrs. Saloni Garg as Senior manager under category of senior management Personnel. (As Per BSE Announcement Dated on 08/11/2023)
04-Aug-2023	11-Aug-2023	Quarterly Results	MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve Medi-caps Limited has informed that the Meeting (02/2023-2024) of the Board of Directors of the Company is scheduled to be held on Friday 11th August 2023 at the Corporate Office of the Company situated at 201 Pushpratna Paradise 9/5 New Palasia Opposite UCO Bank Indore (M.P.) 452001 to transact following businesses along with other routine matters: 1. To consider and approve the Standalone as well as Consolidated Un-Audited Financial Results of the Company for the quarter ended on 30th June 2023 along with the Limited Review Report thereon. 2. To consider the matters relating to the ensuing Annual General Meeting. Board meeting outcome for Board Meeting held on 11th August, 2023 pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015 In compliance with regulation 33 of SEBI (LODR) 2015 board of directors in their meeting held on 11th August 2023 have considered and approved the following businesses: A. un-audited standalone and consolidated financial results for the quarter ended on 30th June 2023 and B. Limited Review Report by the statutory auditors of the Company for the un-audited standalone and consolidated quarter ended on 30th June 2023 Further we are also in process of filling the aforesaid un-audited financial results in the XBRL format within 24 hours from the conclusion of the board meeting In compliance with regulation 33 of SEBI (LODR) 2015 board of directors in their meeting held on 11th August 2023 have considered and approved the following businesses: A. un-audited standalone and consolidated financial results for the quarter ended on 30th June 2023 and B. Limited Review Report by the statutory auditors of the Company for the un-audited standalone and consolidated quarter ended on 30th June 2023 Further we are also in process of filling the aforesaid un-audited financial results in the XBRL format within 24 hours from the conclusion of the board meeting Adoption of New sets of Article of Association subject to approval of Members by special resolution in ensuing AGM. (As Per BSE Announcement Dated on 11.08.2023)
15-May-2023	23-May-2023	Accounts	MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2023 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we are pleased to inform that the Meeting (01/2023-2024) of the Board of the Directors of the Company is scheduled to be held on Tuesday the 23rd May 2023 at the corporate office of the Company situated at 201 Pushpratna Paradise 9/5 New Palasiya Opposite UCO Bank Indore (M.P.) 452001 to transact the following matters:- 1.Consider and Approve the Standalone as well as Consolidated Audited Financial Results of the Company for the fourth quarter as well as financial year ended on 31st March 2023 along with auditors report thereon. 2.Any other matter with the permission of the chair. we would like to inform you that the Board of Directors of the Company in their meeting held on today i.e. 23rd day of May, 2023, has inter alia transacted the following matters:- a) Approval of Audited Standalone and Consolidated Financial Results for the Quarter as well as Financial Year ended 31st March, 2023 along with the Auditors Report thereon, Statement of assets and liabilities, Cash Flow Statement and declaration by the Managing Director & CFO of the Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015; b) Other routine businesses with the permission of chair. The Meeting of the Board of Directors commenced at 3:00 P.M. and concluded at 4:50 P.M. You are requested to please take on record the same. (As Per BSE Announcement Dated on 23.05.2023)
01-Feb-2023	09-Feb-2023	Quarterly Results	Quarterly Results MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 ,inter alia, to consider and approve INTIMATION FOR MEETING OF BOARD OF DIRECTORS (SERIAL NO. 04/2022-23) OF THE COMPANY SCHEDULED TO BE HELD ON THURSDAY, 09TH FEBRUARY, 2023 PURSUANT TO REGULATION 29 OF SEBI (LISTING OBLIGATIONS & DISCLOSURE REQUIREMENTS) REGULATIONS, 2015. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to submit the Un-audited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2022 duly approved by the Board at its meeting held today i.e. 09th February, 2023 along with Limited Review Report given by the Statutory Auditors of the Company, as required under the above said Regulations. You are requested to please take on record the aforesaid Results for your records and reference. (As Per BSE Announcement Dated on 09/02/2023)
03-Nov-2022	10-Nov-2022	Quarterly Results	MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 inter alia to consider and approve With reference to the above mentioned subject and in terms of Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we are pleased to inform that the Meeting (03/2022-2023) of the Board of the Directors of the Company is scheduled to be held on Thursday 10th November 2022 at the Corporate Office of the Company situated at 201 Pushpratna Paradise 9/5 New Palasiya Opposite UCO Bank Indore (M.P.) 452001 to consider and approve the following businesses along with other routine matters:- 1. To consider and approve the Standalone as well as Consolidated Un-Audited Financial Results of the Company for the quarter and half year ended on 30th September 2022 along with the Limited Review Report thereon. 2. Any other matter with the permission of the chair.. We are pleased to inform that, Board of Directors at their meeting held on today i.e. 10th November, 2022 has considered and approved the following business along with the other routine business: (a) Unaudited Standalone and Consolidated Financial Results for the Quarter/Half Year ended on 30th September, 2022; and (b) Limited Review Report by the Auditors for the Unaudited Standalone and Consolidated Financial Results for the Quarter/Half Year ended on 30th September, 2022 (c) Pursuant to Regulation 33(3) (f) and (g) of the Listing Regulations, we have also enclosed Statements of Assets and Liabilities and the Statement of Cash flow in the prescribed format for the quarter as well as half year ended 30th September, 2022. (As per BSE Announcement Dated on 10/11/2022)
26-Jul-2022	04-Aug-2022	Quarterly Results	MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2022 inter alia to consider and approve the following businesses along with other routine matters:- 1. To consider and approve the Standalone as well as Consolidated Un-Audited Financial Results of the Company for the quarter ended on 30th June 2022 along with the Limited Review Report thereon. 2. To consider the matters relating to the ensuing Annual General Meeting. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with sub-para 7 of Para A of Part A of Schedule III to the Listing Regulations, this is to inform you that in the meeting of the Board of Directors of the Company held on today, Thursday, 04th day of August, 2022, Mr. Akshit Garg (DIN: 08576807) has been appointed as an Additional Director as well as Promoter Non-Executive Director of the Company subject to approval of Members in ensuing Annual General Meeting of the Company. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with sub-para 7 of Para A of Part A of Schedule III to the Listing Regulations, this is to inform you that in the meeting of the Board of Directors of the Company held on today, Thursday, 04th day of August, 2022, Mr. Sourabh Kumar Shrivas (DIN: 09692160) has been appointed as an Additional Director as well as Non-Executive Independent Director of the Company for a period of 5 (Five) years with effect from 04th August, 2022 subject to approval of Members in ensuing Annual General Meeting of the Company. (As per BSE Announcement Dated on 05/08/2022) Pursuant to Regulation 30 read with Schedule III Part A(A) and in compliance of Regulation 47(1)(a) of SEBI (LODR) Regulations, 2015 regarding extract of Standalone and Consolidated Un-Audited Financial Results for the quarter ended on 30th June, 2022 which was approved by the Board in their 02/2022-2023 Board Meeting held on Thursday, 04th August, 2022 at the Corporate Office of the Company situated at 201, Pushpratna Paradise 9/5 New Palasiya, Opposite UCO Bank Indore (M.P.) 452001. We have herewith enclosed the newspaper advertisement published on 06th August, 2022 in Free Press Journal English edition and Choutha Sansar Hindi edition. You are requested to please take on record our above said information for your reference and records. (As Per BSE Announcement Dated on 06/08/2022) Outcome of Board Meeting held on 04th August, 2022 pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation,2015 (As Per BSE Announcement Dated 04.08.2022)
17-May-2022	25-May-2022	Accounts	MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 inter alia to consider and approve 1. the Standalone as well as Consolidated Audited Financial Results of the Company for the quarter as well as year ended on 31st March 2022. 2. the Standalone and Consolidated Audited Financial Statements including the Balance Sheet as at 31st March 2022 and the Statement of Profit and Loss and Cash flow Statement of Changes in equity and notes thereon for the year ended 31st March 2022. 3.To take on record the Standalone and Consolidated Auditors Report along with modified/unmodified opinion on the Financial Results for the quarter as well as year ended 31st March 2022. 4. Any other matter with the permission of the chair
02-Feb-2022	10-Feb-2022	Quarterly Results	MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2022 inter alia to consider and approve the Standalone as well as Consolidated Un-audited Quarterly Financial Results of the Company for the quarter and nine months ended on 31st December 2021 along with Limited Review Report and any other matter with the permission of the chair. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to submit the Un-audited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2021 duly approved by the Board at its meeting held today i.e.10th February, 2022 along with Limited Review Report given by the Statutory Auditors of the Company, as required under the above said Regulations. You are requested to please take on record the aforesaid Results for your records and reference. (As Per BSE Announcement Dated on 10/02/2022)
01-Nov-2021	10-Nov-2021	Quarterly Results	Quarterly Results In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to submit the Un-audited Standalone and Consolidated Financial Results for the quarter as well as half year ended 30th September, 2021 duly approved by the Board at its meeting held today i.e.10th November, 2021 along with Limited Review Report given by the Statutory Auditors of the Company, as required under the above said Regulations. Further, pursuant to Regulation 33(3)(f) and (g) of the Listing Regulations, we have also enclosed Statements of Assets and Liabilities and the Statement of Cash flow in the prescribed format for the half year ended 30th September, 2021. Further, copy of Un-Audited Financial Statements shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting. You are requested to please take on record the aforesaid Unaudited Financial Results along with Limited review Report for your records and reference. (As per BSE Announcement Dated on 10/11/2021)
08-Oct-2021	07-Oct-2021	Change in Other Executives	Pursuant to requirement of Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, authorization to the persons for the purpose of determining the materiality of event or information and for making the disclosure to the Stock Exchange as and when required.

1 2

LOGIN HERE

Medi Caps Ltd

Board Meeting